BridgeMD
New treatment option for Male Infertility
Official title Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress
ClinicalTrials.gov ID: NCT07375238
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether drinking a daily serving of gazpacho can improve semen quality in men with reduced sperm quality. The study will also examine how this dietary intervention affects oxidative stress and whether it is well tolerated.
- Time commitment: about 18 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, men only
You may be able to join if
- Men aged 18 to 45 years
- Andrological profile including altered semen parameters such as oligozoospermia, asthenozoospermia and/or teratozoospermia (O±A±T)
- No clinical indication for sperm DNA fragmentation testing or advanced sperm selection techniques
- Willingness and ability to comply with the study protocol, including adherence to a standardized Mediterranean diet
- Signed and dated written informed consent form
You likely can't join if
- Use of antioxidant supplements during the three months prior to study start.
- Active smokers or men who have stopped smoking within the last three months.
- Diagnosis of azoospermia, leucocytospermia or necrozoospermia.
- Presence of severe systemic diseases or chronic conditions that could interfere with semen quality or adherence to the study.
- Known allergy or intolerance to any ingredient of the gazpacho used in the study.
- Any medical, psychological or social condition that, in the investigator's judgement, could compromise the subject's ability to participate fully or...
See the full eligibility criteria
- Men aged 18 to 45 years
- Andrological profile including altered semen parameters such as oligozoospermia, asthenozoospermia and/or teratozoospermia (O±A±T)
- No clinical indication for sperm DNA fragmentation testing or advanced sperm selection techniques
- Willingness and ability to comply with the study protocol, including adherence to a standardized Mediterranean diet
- Signed and dated written informed consent form
- Use of antioxidant supplements during the three months prior to study start.
- Active smokers or men who have stopped smoking within the last three months.
- Diagnosis of azoospermia, leucocytospermia or necrozoospermia.
- Presence of severe systemic diseases or chronic conditions that could interfere with semen quality or adherence to the study.
- Known allergy or intolerance to any ingredient of the gazpacho used in the study.
- Any medical, psychological or social condition that, in the investigator's judgement, could compromise the subject's ability to participate fully or comply with the protocol requirements.
- Simultaneous participation in another clinical study.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 18 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling male, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.